Urosdeoxycholic acid in primary sclerosing cholangitis: a meta-analysis and systematic review.

Arab J Gastroenterol

Division of Gastroenterology, Department of Internal Medicine, Texas Tech University at El Paso, TX, USA.

Published: September 2012

Background And Study Aims: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with no proven effective medical therapy. Ursodeoxycholic acid (UDCA) was proposed as a potential treatment for this disorder. However, several randomised controlled trials reported conflicting results regarding the usefulness of UDCA. The aim of this meta-analysis and systematic review is to investigate the efficacy of UDCA in PSC.

Patients And Methods: Literature review was performed to include randomised controlled trials and non-randomised studies comparing UDCA to a placebo in PSC. The included controlled trials were assigned a quality score. Random effects model was used. Outcomes were measured with Weight Mean Difference, Risk Ratio or Risk Difference. Heterogeneity was measured by I(2) measure of inconsistency.

Results: Seven RCTs satisfied the inclusion criteria with a total number of 553 patients. Low dose UDCA was used in 4 studies, high dose UDCA (17-30mg/kg) was used in three studies. UDCA did not decrease the risk of mortality compared to placebo (RR=1.04, 95% CI 0.46-2.35) or the need for liver transplant (RR=1.22, 95% CI 0.7-2.12). UDCA also had no effect on the clinical symptoms. Liver Function Tests (LFTs) were significantly improved in the UDCA treated patients. UDCA did not decrease the incidence of cholangiocarcinoma.

Conclusion: UDCA had no beneficial effect on the patients' survival, liver histology, prevention of cholangiocarcinoma, or improvement of clinical symptoms. High dose UDCA was associated with increased mortality in one of the large randomised trial included in this analysis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajg.2012.06.011DOI Listing

Publication Analysis

Top Keywords

udca
12
controlled trials
12
dose udca
12
primary sclerosing
8
sclerosing cholangitis
8
meta-analysis systematic
8
systematic review
8
randomised controlled
8
high dose
8
udca decrease
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!